Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Long-term effects of lifestyle and metformin interventions in DPP on bone density.
Why is a 0-fistula rate in pancreaticojejunostomy impossible?
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Why is a 0-fistula rate in pancreaticojejunostomy impossible?
Why is a 0-fistula rate in pancreaticojejunostomy impossible? Surgery. 2021 04; 169(4):721-722.
View in:
PubMed
subject areas
Humans
Pancreas
Pancreatic Fistula
Pancreaticoduodenectomy
Pancreaticojejunostomy
Surgeons
authors with profiles
David B. Adams